Digestive Diseases Center

Led by physicians who pioneered gastrointestinal endoscopy, Cedars-Sinai provides virtually every known gastroenterologic procedure and treatment for digestive diseases and disorders. With inpatient and outpatient programs and state-of-the-art technology, specialized and internationally renowned physicians, and a body of research, clinical expertise and results, the Cedars-Sinai Digestive Disease team treats all disorders with skill and experience.

In its commitment to continually improve the quality of care provided to patients treated at the Digestive Diseases Center, the types and volumes of gastrointestinal endoscopic procedures performed at Cedars-Sinai are monitored and reported. These procedures include:

  • Colonoscopy
  • Esophagogastroduodenoscopy (EGD)
  • Endoscopic retrograde cholangiopancreatography (ERCP)
  • Endoscopic ultrasound (EUS)
  • Double balloon study
  • Wireless capsule procedure

In addition to clinical outcomes, Cedars-Sinai also monitors and reports patient satisfaction with the care they received and their willingness to recommend Cedars-Sinai to others.The data presented reflects the care given by all physicians associated with the Digestive Diseases Center, including staff and attending physicians.

Featured Treatment

gastroenterology program and treatments for digestive disorders

Interventional Gastroenterology

Dr. Simon Lo and his team have pioneered work in capsule endoscopy of the small intestine, including performing the first clinical case in the world and leading a multicenter, comparative study between different capsule platforms. They have also collaborated with other centers to introduce the double-balloon enteroscopy procedure that requires unique training and experience.

Read Full Story

Featured Research

associations found between risk of inflammatory bowel disease and genes inolved in immune-related diseases

Genetic Links for IBD

Researchers of Crohn's disease and ulcerative colitis, sharing raw data and newly collected genetic information from centers around the world, have found associations between risk of inflammatory bowel disease (IBD) and genes involved in immune-related diseases and the immune system's response to pathogens. The study brings together data from 75,000 IBD patients and marks an important step toward honing in on why these illnesses occur and personalizing treatments for them.

Read Full Story